Azalea Vision, a Belgian healthtech company building the first medical-grade smart contact lens, secured €5 million in equity investment from the European Innovation Council (EIC) Fund to advance its medical-grade smart contact lens platform into clinical development.
Azalea Vision is making smart contact lens designed to improve the quality of life of the millions of people living with irregular corneas, higher-order aberrations, and presbyopia. The same device also opens the door to a biosensing platform that can measure a broad range of biomarkers in tears, one of the body’s purest fluids.
Azalea Vision said the new funding is directed at the clinical work ahead, alongside the final engineering steps needed to bring the platform to patients. With core platform functionality established and technical validation nearing completion, the EIC funding further accelerates the transition from proven technology to a certified medical product.